Sichuan Hebang Biotechnology Co (SHSE:603077) Additional Paid-In Capital : ¥0 Mil(As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Sichuan Hebang Biotechnology Co Additional Paid-In Capital?

Sichuan Hebang Biotechnology Co's quarterly additional paid-in capital increased from Sep. 2023 (¥0 Mil) to Dec. 2023 (¥976 Mil) but then stayed the same from Dec. 2023 (¥976 Mil) to Mar. 2024 (¥0 Mil).

Sichuan Hebang Biotechnology Co's annual additional paid-in capital increased from Dec. 2021 (¥322 Mil) to Dec. 2022 (¥440 Mil) and increased from Dec. 2022 (¥440 Mil) to Dec. 2023 (¥976 Mil).

Sichuan Hebang Biotechnology Co Additional Paid-In Capital Historical Data

The historical data trend for Sichuan Hebang Biotechnology Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sichuan Hebang Biotechnology Co Additional Paid-In Capital Chart

Sichuan Hebang Biotechnology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

321.98

439.77

976.05

Sichuan Hebang Biotechnology Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															-	439.77	-	976.05	-

Sichuan Hebang Biotechnology Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Sichuan Hebang Biotechnology Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Sichuan Hebang Biotechnology Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Sichuan Hebang Biotechnology Co (SHSE:603077) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Sichuan Hebang Biotechnology Co Ltd (SHSE:603077) » Definitions » Additional Paid-In Capital

Traded in Other Exchanges

N/A

Address

Number 8, Guangfu Road, Building C6, Qingyang District, Sichuan province, Chengdu, CHN, 610073

Website

http://www.hebang.cn

Sichuan Hebang Biotechnology Co Ltd is engaged in manufacturing chemicals. It provides ammonium chloride which is used as raw material for fertilizers. The other chemical products offered by the company are used in various areas.

Executives

Qin Xue Ling	Director
Wang Jun	Director
Mo Rong	Director
He Zheng Gang	Director
Yang Hong Wu	Director
Li Jing Lin	Director
Yang Hui Rong	Director

Sichuan Hebang Biotechnology Co (SHSE:603077) Headlines

No Headlines